Irregular Sleep Duration Tied to Increased Risk for Developing Diabetes
By Elana Gotkine HealthDay Reporter
FRIDAY, July 19, 2024 -- Irregular sleep duration is associated with elevated diabetes risk, according to a study published online July 17 in Diabetes Care.
Sina Kianersi, Ph.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues examined the association between irregular sleep duration and incident diabetes among 84,421 U.K. Biobank participants (mean age, 62 years) during seven years of follow-up.
The researchers identified 2,058 incident diabetes cases during 622,080 person-years of follow-up. After adjustment for age, sex, and race, compared with sleep duration standard deviation (SD) ≤30 minutes, the hazard ratios (95 percent confidence intervals) were 1.15 (0.99 to 1.33), 1.28 (1.10 to 1.48), 1.54 (1.32 to 1.80), and 1.59 (1.33 to 1.90) for 31 to 45, 46 to 60, 61 to 90, and ≥91 minutes, respectively. A nonlinear association was observed, with a 34 percent higher diabetes risk for individuals with a sleep duration SD of >60 versus ≤60 minutes. The association was attenuated after further adjustment for lifestyle, comorbidities, environmental factors, and adiposity (hazard ratio for sleep duration SD of >60 versus ≤60 minutes, 1.11; 95 percent confidence interval, 1.01 to 1.22). Individuals with a lower diabetes polygenic risk score and longer sleep duration had stronger associations.
"Middle-aged to older adults with inconsistent sleep duration over the week have a heightened risk of developing diabetes relative to their counterparts with more consistent sleep pattern," the authors write.
One author disclosed ties to Versalux and Delos, and is a director and founder of Circadian Health Innovations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-20 03:15
Read more
- Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- Delaying Noncardiac Surgery for Several Months After Heart Attack Found to Be Safer
- More Than Half of Heat Deaths Can Be Blamed on Global Warming: Study
- Ordinal Score Predicts Freedom From Epilepsy One Year After Surgery
- 2022 to 2023 Saw No Change in U.S. Infant Mortality Rate
- AI Model FastGlioma Can Detect Glioma Infiltration During Surgery
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions